Jeffrey V. Poulton, EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 3,237 shares at $250.68 ($812K) on 2024-11-26, disclosed to the SEC on 2024-11-27.
Open-market sale of $812k ALNY by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $247.77 | 30 | $7K | 0.9% |
| 2 | $249.60 | 246 | $61K | 7.6% |
| 3 | $249.60 | 246 | $61K | 7.6% |
| 4 | $250.68 | 364 | $91K | 11.2% |
| 5 | $250.68 | 364 | $91K | 11.2% |
| 6 | $251.42 | 945 |
| $238K |
| 29.2% |
| 7 | $251.42 | 945 | $238K | 29.2% |
| 8 | $252.27 | 97 | $24K | 3.0% |
| Total | $250.97 avg | 3,237 | $812K | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $695K | — | Filing → |
| ALNY | SELL | 2026-01-14 | $1.0M | — | Filing → |
| ALNY | SELL | 2025-10-03 | $3.4M | — | Filing → |